Hinge Health Crushes Q2, Raises Guidance, Acquires Cylinder Health, and Ups Buyback to $496.5M

summarizeSummary

Q2 revenue hit $212.8M (53% YoY growth), full-year guidance was raised, a $105M acquisition of Cylinder Health adds GI care, and the buyback program expanded to $496.5M.

check_boxKey Events · Earnings and Guidance · HNGE

• Q2 Revenue Beats by $11.8M

  Revenue of $212.8M grew 53% YoY, exceeding the $201M consensus estimate. Non-GAAP operating income of $61.5M (29% margin) more than doubled from $26.1M a year ago.

• Full-Year Guidance Raised

  Revenue guidance raised to $856M-$860M (46% YoY growth at midpoint), and non-GAAP operating income guidance raised to $236M-$244M (101% YoY growth), reflecting strong momentum.

• Acquires Cylinder Health for $105M

  Enters gastrointestinal care, a $135B market, by acquiring Cylinder Health for $105M in cash. The deal adds nearly 100 clients and 2M covered lives, with an integrated GI program expected in 2027.

• Buyback Authorization Increased by $300M

  Board increased the share repurchase program by $300M to a total of $496.5M, with $300M available for future repurchases. The company has already bought back $196.5M of stock.

auto_awesomeAnalysis · HNGE · Technology

A standout quarter saw revenue reach $212.8M, up 53% year-over-year and well above the $201M consensus. Full-year revenue guidance was raised to $858M at the midpoint, implying 46% growth, while the non-GAAP operating income outlook jumped by over 100%. In a strategic expansion, the company is acquiring Cylinder Health for $105M in cash, entering the large and underserved gastrointestinal care market. Signaling confidence in the stock, the board also increased the share repurchase authorization by $300M, bringing the total to $496.5M. Together, these announcements mark a major positive inflection point.